[Federal Register: November 30, 2001 (Volume 66, Number 231)]
[Page 59798]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[[Page 59798]]



Food and Drug Administration

Anesthetic and Life Support Drugs Advisory Committee; Notice of 

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Anesthetic and Life Support Drugs Advisory 
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on January 30 and 31, 2002, 
from 8 a.m. to 5 p.m.
    Location: Holiday Inn, The Ballrooms, Two Montgomery Village Ave., 
Gaithersburg, MD.
    Contact: Kimberly Littleton Topper, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, or by delivery to: 5630 Fishers Lane, rm. 1091, 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12529. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: On both days, the committee will discuss the medical use of 
opiate analgesics in various patient populations, including pediatric 
patients and patients with chronic pain of nonmalignant etiology, as 
well as the risk to benefit ratio of extending opiate treatment into 
these populations. It will also address concerns regarding the abuse 
potential, diversion and increasing incidence of addiction to opiate 
analgesics, especially to the modified release opiate analgesics.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by December 21, 
2001. On both days, oral presentations from the public will be 
scheduled between approximately 8:30 a.m. and 9:30 a.m. Time allotted 
for each presentation may be limited. Those desiring to make formal 
oral presentations should notify the contact person before December 21, 
2001, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: November 21, 2001.
Bonnie Malkin,
Acting Senior Associate Commissioner for Communications and Constituent 
[FR Doc. 01-29741 Filed 11-29-01; 8:45 am]